ALGAE
Fermentalg SA provides biosolutions based on aquatic micro-organisms in Europe, North America, Asia, and internationally. It offers DHA ORIGINS, a plant-based DHA oil; KALVEA PLUS, a nutritious algal protein concentrate dedicated to aquafeed applications; Everzure, an extract of natural acid stable blue color; BLUE ORIGINS AOX, an antioxidant and anti-inflammatory activities; and biobased raw mat… Read more
Market Cap & Net Worth: ALGAE (ALGAE)
ALGAE (PA:ALGAE) has a market capitalization of $45.88 Million (€44.70 Million) as of March 19, 2026. Listed on the PA stock exchange, this France-based company holds position #23676 globally and #202 in its home market, demonstrating a 11.63% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying ALGAE's stock price €0.47 by its total outstanding shares 96024432 (96.02 Million).
ALGAE Market Cap History: 2025 to 2026
ALGAE's market capitalization history from 2025 to 2026. Data shows growth from $42.04 Million to $45.88 Million (0.00% CAGR).
ALGAE Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how ALGAE's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of ALGAE by Market Capitalization
Companies near ALGAE in the global market cap rankings as of March 19, 2026.
Key companies related to ALGAE by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #165 globally with a market cap of $114.33 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #285 globally with a market cap of $73.32 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #340 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #497 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #165 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $114.33 Billion | $451.59 |
| #285 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $73.32 Billion | $744.12 |
| #340 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #497 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
ALGAE Historical Marketcap From 2025 to 2026
Between 2025 and today, ALGAE's market cap moved from $42.04 Million to $ 45.88 Million, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €45.88 Million | +9.14% |
| 2025 | €42.04 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 19th, 2026 the market cap of ALGAE was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $45.88 Million USD |
| MoneyControl | $45.88 Million USD |
| MarketWatch | $45.88 Million USD |
| marketcap.company | $45.88 Million USD |
| Reuters | $45.88 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.